Russia’s Sputnik V vaccine shows 96.3% COVID-19 efficacy in Belarus: RDIF

Russia’s Sputnik V vaccine has demonstrated 96.3% efficacy against COVID-19 during the vaccination campaign in Belarus, Russia’s RDIF sovereign wealth fund said on Wednesday, down from 97.2% efficacy reported in September.

The Russian Direct Investment Fund, which is marketing the two-shot vaccine abroad, said the study was based on data from more than 1.2 million people who had been vaccinated with both Sputnik V components between January and September 2021.

Meanwhile, many countries are rolling out COVID-19 vaccine booster shots, but there is no consensus among scientists that they are necessary and the World Health Organization wants the most vulnerable people worldwide to be fully vaccinated first.
Here are some of the options countries and regions are considering:

NORTH AMERICA

The U.S. Centers for Disease Control and Prevention (CDC) on Sept. 24 backed a booster shot of the Pfizer and BioNTech vaccine for Americans aged 65 and older, some adults with underlying medical conditions and some adults in high-risk working and institutional settings.

Canada’s National Advisory Committee on Immunization is recommending booster shots of an authorized mRNA vaccine to those who are moderately or severely immunocompromised.

EUROPE
The European Union’s drug regulator recommended on Oct. 4 a third dose of Pfizer-BioNTech and Moderna mRNA vaccines for those with a severely weakened immune system, but left it to member states to decide whether the wider population should geta booster.
Recent contracts with Pfizer/BioNTech and Moderna have included the potential for the bloc to buy booster shots.

These European countries are offering boosters to adults after they receive a full dose of a vaccine:

** Austria; Czech Republic; Germany; Hungary; Italy (Pfizeror Moderna booster shots for all inoculated, and for all those who have received a single dose of the Johnson & Johnson vaccine; Malta (all over-12s); Norway; Poland; Russia; Romania(only boosters from Pfizer or Moderna were approved); Serbia; Slovakia; Spain (Pfizer or Moderna booster shots for all inoculated with J&J)

These countries are offering boosters to people with weakimmune systems, the elderly or vulnerable:

** Belgium (mRNA); Bulgaria; Britain (plans to extendrollout to over-40s from over-50s); Denmark; Finland (may expandto other Finns later in the autumn); France (so far availableonly to over-65s, will be offered to over-50s from December);Ireland; Italy; Lithuania; Netherlands (over-60s); Portugal;Slovenia; Spain; Sweden (larger population to get a jab in2022); Switzerland (new recommendation for people under 65expected in the next few weeks)

AFRICA

** Morocco, which has administered the most doses in Africa,bstarted giving a third dose beginning in October.
** Tunisia (5 months after second dose)
** Nigeria is trying to secure booster shots, the head of the presidential steering committee on COVID-19 said on Nov 15.

ASIA, MIDDLE EAST

These countries are offering boosters to adults after they receive a full dose:
** Bahrain (Sputnik V, all over-18s at least six months after second dose); Cambodia (AstraZeneca); Indonesia (healthworkers only, wider population planned in 2022); Israel (allover-12s); South Korea (initial doses to high-risk groups orpeople with weakened immune systems); Turkey; Thailand(AstraZeneca or mRNA-type booster shots to people who were administered Sinovac brand); UAE (mandatory for people inoculated with Sinopharm vaccine)
These countries are offering boosters to people with weak immune systems, the elderly or vulnerable:
** China; Hong Kong; Singapore

AUSTRALIA began administering Pfizer COVID booster shots in November to fully vaccinated adults.

LATIN & CENTRAL AMERICA

These countries are offering boosters to adults after they receive a full dose:
** Brazil; Uruguay (offers a Pfizer dose for those fully vaccinated with Sinovac)
These countries are offering boosters only to the immunosuppressed:
** Ecuador, Panama
These are offering boosters to elderly, vulnerable and at-risk people:
** Chile; Brazil; Dominican Republic, El Salvador (elderly, health workers, people with underlying health conditions)

COMPANIES

The U.S. Food and Drug Administration authorized on Sept. 22a booster dose of the Pfizer and BioNTech COVID-19 vaccine for those 65 and older, all people at high risk of severe disease, and others who are regularly exposed to the virus.

The FDA authorized a third dose by Pfizer-BioNTech and Moderna Inc on Aug. 13 for people with compromised immune systems.

Pfizer and BioNTech have also requested FDA approval for the use of their booster shots for all adults.
The FDA cleared in October booster shots of vaccines from Moderna and J&J.

The European Union’s drug regulator (EMA) authorised the use of Moderna and Pfizer COVID-19 booster shots for over-18s, at least six months after the second dose.

EMA is also considering an authorisation for AstraZeneca’s booster dose.
Canada authorised booster dose of Moderna and Pfizer vaccines for adults.